Not finding it? Sign in to also search OpenAlex live.
-
Abstract OT1-04-04: AXSANA - EUBREAST 3 (axillary surgery after neoadjuvant treatment): An international prospective multicenter cohort study of the EUBREAST study group to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)2022 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Thorsten Kühn, Steffi Hartmann, Elmar Stickeler, Jana de Boniface, Oreste Gentilini, Sarah Fröhlich, +28 more
0citations -
Abstract OT-04-02: The AXSANA trial (AXillary Surgery After NeoAdjuvant treatment): An international prospective multicenter cohort study of the EUBREAST study group to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)2021 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Maggie Banys‐Paluchowski, Elmar Stickeler, Jana de Boniface, Oreste Gentilini, Marc Thill, Steffi Hartmann, +6 more
0citations -
Lateral lymph node dissection after neoadjuvant (chemo)radiotherapy may improve oncological outcomes in Western patients with low rectal cancer.2020 Journal of Clinical Oncology conference-abstract Medicine Colorectal Cancer Surgical Treatments
Hidde Maarten Kroon, Songphol Malakorn, Nagendra Naidu Dudi-Venkata, Sergei Bedrikovetski, Brian K. Bednarski, Atsushi Ogura, +7 more
4citations -
Cohort study of patients with oligorecurrent prostate cancer: Oncological outcomes of patients treated with salvage lymph node dissection via PSMA radioguided surgery.2022 Journal of Clinical Oncology conference-abstract Medicine Prostate Cancer Diagnosis and Treatment
Sophie Knipper, Mehrdad Mehdi Irai, Ricarda Simon, Daniel Koehler, Isabel Rauscher, Matthias J. Eiber, +11 more
0citations -
Cohort study of oligorecurrent prostate cancer patients: Oncological outcomes of patients treated with salvage lymph node dissection via PSMA radioguided surgery.2022 Journal of Clinical Oncology conference-abstract Medicine Prostate Cancer Diagnosis and Treatment
Tobias Maurer, Mehrdad Mehdi Irai, Isabel Rauscher, Ricarda Simon, Matthias J. Eiber, Fijs W. B. van Leeuwen, +8 more
0citations -
An international randomized phase III trial comparing radical hysterectomy and pelvic node dissection (RH) vs simple hysterectomy and pelvic node dissection (SH) in patients with low-risk early-stage cervical cancer (LRESCC): A Gynecologic Cancer Intergroup study led by the Canadian Cancer Trials Group (CCTG CX.5-SHAPE).2023 Journal of Clinical Oncology conference-abstract Medicine Endometrial and Cervical Cancer Treatments Open access
Marie Plante, Janice S. Kwon, Sarah Elizabeth Ferguson, Vanessa Samouëlian, Gwénaël Ferron, Amandine Maulard, +14 more
27citations -
Abstract GS2-11: Omission of sentinel lymph node biopsy in clinically T1-2 node-negative breast cancer patients treated with breast-conserving therapy: results of the Dutch BOOG 2013-08 randomized controlled trial after a median follow-up of 5 years2026 Clinical Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
R. J. Schipper, L. van Roozendaal, V. Wintraecken, J.M. Simons, Martine Moossdorff, E.J.T. Luiten, +36 more
6citations -
Comparison of marking techniques for target lymph nodes in 2,596 patients with node-positive breast cancer treated with neoadjuvant chemotherapy: Results from the prospective multicenter AXSANA/EUBREAST-03/AGO-B-053 study (NCT04373655).2025 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Maggie Banys‐Paluchowski, Steffi Hartmann, Nina Ditsch, Jana de Boniface, Oreste Gentilini, Elmar Stickeler, +14 more
2citations -
Abstract GS2-01: More versus less invasive axillary surgical staging procedures in breast cancer patients converting from a clinically node-positive to a clinically node-negative stage through neoadjuvant chemotherapy - primary endpoint analysis of the international prospective multicenter AXSANA/EUBREAST 3(R)study2026 Clinical Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Thorsten Kühn, M. Banys-Paluchowski, Nina Caroline Ditsch, Elmar Stickeler, Michael Hauptmann, J. Schroth, +43 more
4citations -
Abstract PO3-23-03: Radar reflectors for marking of target lymph nodes in patients receiving neoadjuvant chemotherapy for breast cancer – a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial2024 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Maggie Banys‐Paluchowski, Steffi Hartmann, Jana de Boniface, Oreste Gentilini, Timo Basali, Elmar Stickeler, +23 more
0citations -
Radar reflectors for marking of target lymph nodes in patients receiving neoadjuvant chemotherapy for breast cancer: A subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.2024 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Maggie Banys‐Paluchowski, Timo Basali, Steffi Hartmann, Jana de Boniface, Oreste Gentilini, Elmar Stickeler, +13 more
0citations -
Abstract PO4-19-04: AXSANA – EUBREAST-3: An international prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy2024 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Thorsten Kühn, Steffi Hartmann, Elmar Stickeler, Jana de Boniface, Oreste Gentilini, Sarah Fröhlich, +36 more
1citations -
Prediction of axillary response in 5,262 patients with node-positive breast cancer treated with neoadjuvant chemotherapy: Results from the prospective multicenter AXSANA/EUBREAST-03/AGO-B-053 study.2026 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Maggie Banys‐Paluchowski, Thorsten Kühn, Steffi Hartmann, Jana de Boniface, Nina Caroline Ditsch, Oreste Gentilini, +15 more
0citations -
Abstract PO1-23-02: Magnetic seeds used for the detection of target lymph nodes after neoadjuvant therapy for early breast cancer – a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial2024 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Hans‐Christian Kolberg, Steffi Hartmann, Maggie Banys‐Paluchowski, Elmar Stickeler, Jana de Boniface, Oreste Gentilini, +9 more
0citations -
First safety and efficacy results of PRADO: A phase II study of personalized response-driven surgery and adjuvant therapy after neoadjuvant ipilimumab (IPI) and nivolumab (NIVO) in resectable stage III melanoma.2020 Journal of Clinical Oncology conference-abstract Medicine Cutaneous Melanoma Detection and Management
Christian U. Blank, Irene L. M. Reijers, Thomas E. Pennington, Judith M. Versluis, Robyn P.M. Saw, Elisa A. Rozeman, +14 more
62citations -
Survival data of PRADO: A phase 2 study of personalized response-driven surgery and adjuvant therapy after neoadjuvant ipilimumab (IPI) and nivolumab (NIVO) in resectable stage III melanoma.2022 Journal of Clinical Oncology conference-abstract Medicine Cutaneous Melanoma Detection and Management
Christian U. Blank, Irene L. M. Reijers, Robyn P.M. Saw, Judith M. Versluis, Thomas E. Pennington, Ellen Kapiteijn, +14 more
17citations -
Neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in macroscopic, resectable stage III melanoma: The phase 3 NADINA trial.2024 Journal of Clinical Oncology conference-abstract Medicine Cutaneous Melanoma Detection and Management Open access
Christian U. Blank, Minke W. Lucas, Richard A. Scolyer, Bart A. van de Wiel, Alexander Maxwell Menzies, Marta López‐Yurda, +14 more
27citations -
The impact of response-directed surgery and adjuvant therapy on long-term survival after neoadjuvant ipilimumab plus nivolumab in stage III melanoma: Three-year data of PRADO and OpACIN-neo.2023 Journal of Clinical Oncology conference-abstract Medicine Cutaneous Melanoma Detection and Management
Irene L. M. Reijers, Alexander Maxwell Menzies, Judith M. Versluis, Robyn P.M. Saw, Winan J. van Houdt, Ellen Kapiteijn, +14 more
10citations -
Quality of life with neoadjuvant ipilimumab (IPI) and nivolumab (NIVO) versus adjuvant nivolumab in resectable stage III melanoma: 36-week data from the phase 3 NADINA trial.2024 Journal of Clinical Oncology conference-abstract Medicine Cutaneous Melanoma Detection and Management
Minke W. Lucas, Reetta Arokoski, Alexander Maxwell Menzies, Saskia M. Pulleman, Robyn P.M. Saw, Winan J. van Houdt, +14 more
2citations -
The NADINA trial: A multicenter, randomised, phase 3 trial comparing the efficacy of neoadjuvant ipilimumab plus nivolumab with standard adjuvant nivolumab in macroscopic resectable stage III melanoma.2022 Journal of Clinical Oncology conference-abstract Medicine Cutaneous Melanoma Detection and Management
Minke W. Lucas, J. Lijnsvelt, Saskia M. Pulleman, Richard A. Scolyer, Alexander Maxwell Menzies, Alexander C. J. van Akkooi, +13 more
47citations
20 results